News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
297,674 Results
Type
Article (16684)
Company Profile (305)
Press Release (280678)
Multimedia
Podcasts (81)
Webinars (13)
Section
Business (83108)
Career Advice (413)
Deals (13933)
Drug Delivery (42)
Drug Development (51641)
Employer Resources (49)
FDA (6249)
Job Trends (5674)
News (150718)
Policy (10740)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1005)
Accelerated approval (20)
Adcomms (17)
Allergies (83)
Alliances (22637)
ALS (131)
Alzheimer's disease (1061)
Antibody-drug conjugate (ADC) (242)
Approvals (6442)
Artificial intelligence (270)
Autoimmune disease (117)
Automation (10)
Bankruptcy (114)
Best Places to Work (4993)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (232)
Bladder cancer (102)
Brain cancer (46)
Breast cancer (349)
Cancer (3180)
Cardiovascular disease (257)
Career advice (366)
Career pathing (11)
CAR-T (221)
CDC (10)
Cell therapy (568)
Cervical cancer (15)
Clinical research (44454)
Collaboration (1171)
Company closure (2)
Compensation (597)
Complete response letters (40)
COVID-19 (1161)
CRISPR (86)
C-suite (564)
Cystic fibrosis (112)
Data (4415)
Denatured (16)
Depression (93)
Diabetes (264)
Diagnostics (1579)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (189)
Drug pricing (52)
Drug shortages (4)
Duchenne muscular dystrophy (226)
Earnings (32567)
Editorial (30)
Employer branding (10)
Employer resources (44)
Events (53586)
Executive appointments (646)
FDA (8044)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (11)
Frontotemporal dementia (22)
Funding (999)
Gene editing (183)
Generative AI (22)
Gene therapy (498)
GLP-1 (520)
Government (1320)
Grass and pollen (3)
Guidances (170)
Healthcare (7305)
HIV (19)
Huntington's disease (44)
IgA nephropathy (74)
Immunology and inflammation (193)
Immuno-oncology (42)
Indications (67)
Infectious disease (1272)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (41)
Intellectual property (167)
Interviews (95)
IPO (7545)
IRA (14)
Job creations (960)
Job search strategy (303)
JPM (42)
Kidney cancer (9)
Labor market (25)
Layoffs (259)
Leadership (16)
Legal (1534)
Liver cancer (48)
Longevity (11)
Lung cancer (424)
Lymphoma (257)
Machine learning (24)
Management (14)
Manufacturing (392)
MASH (132)
Medical device (2994)
Medtech (3005)
Mergers & acquisitions (7018)
Metabolic disorders (750)
Multiple sclerosis (112)
NASH (13)
Neurodegenerative disease (242)
Neuropsychiatric disorders (72)
Neuroscience (2012)
Neurotech (1)
NextGen: Class of 2026 (2314)
Non-profit (1120)
Now hiring (30)
Obesity (342)
Opinion (141)
Ovarian cancer (135)
Pain (106)
Pancreatic cancer (165)
Parkinson's disease (232)
Partnered (16)
Patents (303)
Patient recruitment (333)
Peanut (44)
People (27714)
Pharmaceutical (46)
Pharmacy benefit managers (6)
Phase 1 (15590)
Phase 2 (20589)
Phase 3 (13229)
Pipeline (3325)
Policy (98)
Postmarket research (906)
Preclinical (6606)
Press Release (30)
Prostate cancer (146)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (661)
Real estate (1648)
Recruiting (20)
Regulatory (10351)
Reports (22)
Research institute (1040)
Resumes & cover letters (37)
Rett syndrome (25)
RNA editing (21)
RSV (17)
Schizophrenia (124)
Series A (184)
Series B (138)
Service/supplier (2)
Sickle cell disease (78)
Special edition (19)
Spinal muscular atrophy (134)
Sponsored (16)
Startups (2058)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (20)
The Weekly (64)
Vaccines (360)
Venture capital (71)
Weight loss (184)
Women's health (27)
Worklife (4)
Date
Today (51)
Last 7 days (336)
Last 30 days (1195)
Last 365 days (18244)
2026 (1740)
2025 (18512)
2024 (21035)
2023 (22968)
2022 (28271)
2021 (29363)
2020 (24717)
2019 (17753)
2018 (12922)
2017 (14476)
2016 (12733)
2015 (15304)
2014 (11055)
2013 (8048)
2012 (8135)
2011 (8271)
2010 (7912)
Location
Africa (212)
Alabama (66)
Alaska (2)
Arizona (74)
Arkansas (5)
Asia (19150)
Australia (3238)
California (7225)
Canada (1863)
China (780)
Colorado (249)
Connecticut (259)
Delaware (237)
Europe (40892)
Florida (918)
Georgia (210)
Hawaii (2)
Idaho (17)
Illinois (411)
India (35)
Indiana (180)
Iowa (8)
Japan (227)
Kansas (81)
Kentucky (9)
Louisiana (9)
Maine (11)
Maryland (748)
Massachusetts (5730)
Michigan (111)
Minnesota (251)
Mississippi (3)
Missouri (33)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (25)
New Jersey (1735)
New Mexico (14)
New York (1788)
North Carolina (841)
North Dakota (6)
Northern California (3541)
Ohio (183)
Oklahoma (11)
Oregon (27)
Pennsylvania (1285)
Puerto Rico (9)
Rhode Island (30)
South America (283)
South Carolina (9)
Southern California (2868)
Tennessee (41)
Texas (924)
United States (23895)
Utah (100)
Virginia (142)
Washington D.C. (39)
Washington State (596)
West Virginia (1)
Wisconsin (46)
297,674 Results for "walking fish therapeutics inc.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Walking Fish Therapeutics Expands Leadership Team
Walking Fish Therapeutics, a leader in B cell engineering, announced the promotion of Julie Kim, PharmD, MS, to Chief Business Officer.
June 1, 2023
·
3 min read
Press Releases
Kerecis Fish-Skin Technology to Make a Splash at SAWC Fall 2025
September 3, 2025
·
5 min read
Business
MaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform
MaxCyte, Inc. today announced the signing of a strategic platform license (SPL) with Walking Fish Therapeutics , Inc. a biotechnology company that is rapidly advancing B cell-based therapeutics.
May 4, 2023
·
3 min read
Cell therapy
How Takeda Built Its Cell Therapy Portfolio, Only To Walk Away
Takeda wanted to create something new in the cell therapy world by combining the technology with T cell engagers. A series of acquisitions in 2021 started the process.
October 8, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
October 9, 2025
·
5 min read
Press Releases
U.S. Food and Drug Administration Authorizes CytoCell KMT2A Breakapart FISH Probe Kit PDx as a New Companion Diagnostic for KMT2A rearranged Acute Leukaemia
September 23, 2025
·
6 min read
Biotech Bay
Walking Fish Therapeutics Closes $73 Million Series A Financing
Walking Fish Therapeutics , a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising a total of $73 million.
February 16, 2022
·
2 min read
Earnings
Lilly Walks Pricing Tightrope With Upcoming Weight Loss Pill Orforglipron
CEO David Ricks wants Eli Lilly’s upcoming obesity pill to be accessible to patients who need it, but the company still needs to pay for the next generation of obesity medicines to come after that.
October 30, 2025
·
4 min read
·
Annalee Armstrong
Leadership
Leadership Lab: How To Spot When Employees Are About To Walk Away
Employees rarely leave companies for one reason alone. In this column, Kaye/Bassman’s Michael Pietrack shares a framework that helps leaders identify when their team members are thinking about heading for the exit—and how to address it.
October 22, 2025
·
7 min read
·
Michael Pietrack
Business
Walking Fish Therapeutics Expands Leadership Team and Debuts New Headquarters as it Advances Its B Cell Therapeutics Towards Clinical Trials
Walking Fish Therapeutics, a leader in B cell engineering, announced it has appointed Georgia Erbez as Chief Operating Officer and moved to a new 22,000 square foot office and world-class laboratory in South San Francisco.
September 6, 2022
·
1 min read
1 of 29,768
Next
